Nevada 2019 Regular Session Status: Passed Assembly

AB 340 — Makes various changes concerning the acquisition and use of opioid antagonists by schools. (BDR 40-849)

Last action — (No further action taken.)

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2019 Regular Session. It reached “Passed Assembly” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

AN ACT relating to controlled substances; authorizing certain health care professionals to issue an order for an opioid antagonist to a public or private school; authorizing public and private schools to obtain and maintain opioid antagonists under certain conditions; providing immunity to health care professionals and pharmacists for acts or omissions relating to the acquisition, possession or administration of opioid antagonists in certain circumstances; and providing other matters properly relating thereto.

Bill Text

What changed in the latest version

267 added · 284 removed

267 line(s) added, 284 removed.

→
Previous
Latest
A.B.
(Reprinted with amendments adopted on May 20, 2019) FIRST REPRINT A.B.
providing immunity to certain persons for acts or omissions relating to the acquisition, possession or administration of opioid antagonists in certain circumstances;
providing immunity to health care professionals and pharmacists for acts or omissions relating to the acquisition, possession or administration of opioid antagonists in certain circumstances;
Existing law authorizes certain physicians, physician assistants and advanced at risk of experiencing an opioid-related drug overdose, or to a family member,person friend or other person who is in a position to assist a person experiencing an opioid- related drug overdose.
Existing law authorizes certain physicians, physician assistants and advanced practice registered nurses to prescribe and dispense an opioid antagonist to a person at risk of experiencing an opioid-related drug overdose, or to a family member, friend or other person who is in a position to assist a person experiencing an opioid- authorizes certain health care professionals to issue an order for auto-injectable epinephrine to a public or private school to be maintained at the school for the treatment of anaphylaxis that may be experienced by any pupil at the school.
(Chapter 453C of NRS, NRS 453C.100) Existing law also authorizes certain health care professionals to issue an order for auto-injectable epinephrine to a public or private school to be maintained at the school for the treatment of anaphylaxis that may be experienced by any pupil at the school.
(NRS 630.374, 632.239, 633.707) Section 1 of this bill authorizes certain health care professionals to issue such an order for opioid antagonists to a public or private by any person at the school.
(NRS professionals to issue such an order for opioid antagonists to a public or private school for the treatment of an opioid-related drug overdose that may be experienced by any person at the school.
Existing law requires each public school, including each charter school, to obtain an order from certain health care professionals for auto-injectable similarly authorizes a private school to obtain and maintain auto-injectable - *AB340* – 2 – epinephrine at the school.
Existing law requires each public school, including each charter school, to obtain an order from certain health care professionals for auto-injectable epinephrine to maintain the drug at the school.
(NRS 386.870) Existing law - *AB340_R1* – 2 – similarly authorizes a private school to obtain and maintain auto-injectable epinephrine at the school.
If a public or private school obtains such an order, sections 2, 4 and 7 of this bill authorize a school nurse or other designated employee of the public or private school, as applicable, who has received training in the storage and administration of opioid school who is reasonably believed to be experiencing an opioid-related drugs of the overdose.
If a public or private school obtains such an order, sections 2, 4 and 7 of this bill authorize a school nurse or other designated employee of the public or private school, as antagonists to administer an opioid antagonist to any person on the premises of the school who is reasonably believed to be experiencing an opioid-related drug overdose.
and (2) requires each school district and charter school to report to the Division of Public and Behavioral Health of the Department of Health and Human Services the number of doses of opioid antagonists administered at each public school during each school year.
and (2) requires each school district and charter school to report to the Division of Public and Behavioral Health of the Department of Health and Human Services the number of doses of opioid antagonists administered at each public school during each school governing body of each charter or private school that obtains an order for an opioid antagonist to establish a policy to ensure:
Sections 4 and 7 require the board of trustees of each school district and the antagonist to establish a policy to ensure:
(1) that someone seeks emergency assistance each time a person experiences an opioid-related drug overdose on the premises of the school;
(1) that someone seeks emergencyn opioid assistance each time a person experiences an opioid-related drug overdose on the premises of the school;
Sections 4-7 of this bill require training in the storage and administration of opioid antagonists to be provided to designated employees of a public or private school that obtains an order for an opioid antagonist.
Sections 4-7 of this bill require training in the storage and administration of opioid antagonists to be provided to designated employees of a public or private school that obtains an order forSection 8 of this bill requires a registered pharmacist to transfer an order for an opioid antagonist to another registered pharmacist at the request of a public or private school for which the order was issued.
Sections 4 and 7 exempt a school, school district, liability for certain damages relating to the acquisition, possession, provision or administration of an opioid antagonist or auto-injectable epinephrine not amounting to gross negligence or reckless, willful or wanton conduct.
Section 8 also exempts a pharmacist who dispenses an opioid antagonist pursuant to such an order from liability for certain damages relating to the acquisition, possession, provision or administration of an opioid antagonist not amounting to gross negligence or reckless, willful or wanton conduct.
Section 8 of this bill requires a registered pharmacist to transfer an order for an opioid antagonist to another registered pharmacist at the request of a public or private school for which the order was issued.
Section 8 also exempts a pharmacist certain damages relating to the acquisition, possession, provision or administration of an opioid antagonist not amounting to gross negligence or reckless, willful or wanton conduct.
- *AB340* – 3 – (b) The classification of the license of the health care professional;
(b) The classification of the license of the health care professional;
(c) The name of the public or private school to which the order is issued;
- *AB340_R1* – 3 – (c) The name of the public or private school to which the order is issued;
Not later than 30 days after the last day of each school year, each school district and charter school shall submit a report to the Division of Public and Behavioral Health of the Department of - *AB340* – 4 – Health and Human Services identifying the number of doses of auto-injectable epinephrine and opioid antagonists that were administered at each public school within the school district or charter school, as applicable, during the school year.
Not later than 30 days after the last day of each school year, each school district and charter school shall submit a report to the Division of Public and Behavioral Health of the Department of Health and Human Services identifying the number of doses of auto-injectable epinephrine and opioid antagonists that were - *AB340_R1* – 4 – administered at each public school within the school district or charter school, as applicable, during the school year.
[4.] (b) An opioid antagonist maintained at the school to any person on the premises of the public school whom the school - *AB340* – 5 – nurse or other designated employee reasonably believes is experiencing an opioid-related drug overdose.
[4.] (b) An opioid antagonist maintained at the school to any person on the premises of the public school whom the school nurse or other designated employee reasonably believes is experiencing an opioid-related drug overdose.
5.
- *AB340_R1* – 5 – 5.
A public school, school district, member of the board of trustees of a school district or governing body of a charter school or employee of a school district or charter school is not liable for any error or omission concerning the acquisition, possession, provision or administration of auto-injectable epinephrine or an opioid antagonist maintained at a public school pursuant to this section not resulting from gross negligence or reckless, willful or wanton conduct of the school, school district, member or employee, as applicable.
8.
Each charter school shall ensure that each person [so] designated to administer medication pursuant to subsection 1 or 2 - *AB340* – 6 – receives training in the proper storage and administration of auto- injectable epinephrine [.] or opioid antagonists, as applicable.
Each charter school shall ensure that each person [so] designated to administer medication pursuant to subsection 1 or 2 receives training in the proper storage and administration of auto- injectable epinephrine [.] or opioid antagonists, as applicable.
or (b) Is employed by a state, county, city or district health department and provides nursing services to the school district in the course of that employment.
or - *AB340_R1* – 6 – (b) Is employed by a state, county, city or district health department and provides nursing services to the school district in the course of that employment.
If a dose of an opioid antagonist maintained by the private school is used or expires, the - *AB340* – 7 – private school may obtain an additional dose of the opioid antagonist to replace the used or expired opioid antagonist.
If a dose of an opioid antagonist maintained by the private school is used or expires, the private school may obtain an additional dose of the opioid antagonist to replace the used or expired opioid antagonist.
(a) Auto-injectable epinephrine maintained at the school to any pupil on the premises of the private school during regular school hours whom the school nurse or other trained employee reasonably believes is experiencing anaphylaxis.
- *AB340_R1* – 7 – (a) Auto-injectable epinephrine maintained at the school to any pupil on the premises of the private school during regular school hours whom the school nurse or other trained employee reasonably believes is experiencing anaphylaxis.
A private school or member of the governing body or employee thereof is not liable for any error or omission concerning the acquisition, possession, provision or administration of auto-injectable epinephrine or an opioid antagonist maintained at the private school pursuant to this section not resulting from gross negligence or reckless, willful or wanton conduct of the school, member or employee, as applicable.
8.
- *AB340* – 8 – Sec.
Sec.
A pharmacist is not liable for any error or omission concerning the acquisition, possession, provision or administration of auto-injectable epinephrine or an opioid antagonist that the pharmacist has dispensed to a public or private school or authorized entity pursuant to an order issued pursuant to NRS 630.374, 632.239 , [or] 633.707 or section 1 of this act not resulting from gross negligence or reckless, willful or wanton conduct of the pharmacist.
A pharmacist is not liable for any error or omission concerning the acquisition, possession, provision or administration of auto-injectable epinephrine or an opioid antagonist that the - *AB340_R1* – 8 – entity pursuant to an order issued pursuant to NRS 630.374, 632.239d , [or] 633.707 or section 1 of this act not resulting from gross negligence or reckless, willful or wanton conduct of the pharmacist.
H - *AB340*
H - *AB340_R1*
View plain text versions (2)

Amendments

1 amendment

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. (No further action taken.)

  2. In Assembly.

  3. Read third time. Passed, as amended. Title approved, as amended. (Yeas: 21, Nays: None.) To Assembly.

  4. Taken from General File. Placed on General File for next legislative day.

  5. Taken from General File. Placed on General File for next legislative day.

  6. From printer. To engrossment. Engrossed. First reprint. Taken from General File. Placed on General File for next legislative day.

  7. From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 746.) To printer.

  8. In Senate. Read first time. Referred to Committee on Health and Human Services. To committee.

  9. Read third time. Passed. Title approved. (Yeas: 40, Nays: 1, Excused: 1.) To Senate.

  10. Read second time.

  11. From committee: Do pass.

  12. From printer. To committee.

  13. Read first time. Referred to Committee on Health and Human Services. To printer.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

5 sponsors · 0 co-sponsors · 62 not signed on

Sponsors (5)

Co-sponsors (0)

None.

Not signed on (62)

62 members have not signed on to this bill.

Show all 62 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does AB 340 do?
AN ACT relating to controlled substances; authorizing certain health care professionals to issue an order for an opioid antagonist to a public or private school; authorizing public and private schools to obtain and maintain opioid antagonists under certain conditions; providing immunity to health care professionals and pharmacists for acts or omissions relating to the acquisition, possession or administration of opioid antagonists in certain circumstances; and providing other matters properly relating thereto.
Who sponsors AB 340?
AB 340 is sponsored by Assemblywoman Robin Titus, Assemblyman John Ellison, Al Kramer, Jim Wheeler, and John Hambrick.
What is the current status of AB 340?
This bill died with 2019 Regular Session. It reached “Passed Assembly” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track AB 340?
Track AB 340 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on AB 340

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of AB 340

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →